Become a member of BioTechniques (it's free!) and receive the latest news in the life sciences and member-exclusives.

Peek behind the paper: solid lipid nanoparticles as potential non-viral vectors for CRISPR/Cas9 delivery

Written by The Nanomed Zone, HASAN AKBABA (EGE UNIVERSITY)
Interviews Nanomedicine

In this behind-the-paper interview, part of our ‘In Focus’ feature on functional nanomaterials in cancer therapy, to coincide with the recently published Nanomedicine Special Focus Issue on this topic, Hasan Akbaba (Ege University, Bornova, Turkey) discusses research exploring the use of solid lipid nanoparticles (SLNs) as non-viral vectors for CRISPR/Cas9 delivery. Read the full research paper, part of the Nanomedicine Special Focus Issue, here >>> Please could you introduce yourself, your organization and provide a brief overview of your career to date? I am currently an Assistant Professor in the Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, at Ege University. I...

To view this content, please register now for access

Join our member community for FREE to access a collection of journal and online-only features, including:

  • Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
  • The latest news and journal updates delivered straight to your inbox when you want it
  • Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
  • Priority registration to webinars, panel discussions and events
  • Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!